GT
ATRC icon

Glenmede Trust’s AtriCure ATRC Stock Holding History

Glenmede Trust’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-29
Closed – – 2441
2020
Q1 		$0 Hold
29
– – ﹤0.01% 3002
2019
Q4 		$0 Hold
29
– – ﹤0.01% 3009
2019
Q3 		$0 Hold
29
– – ﹤0.01% 3007
2019
Q2 		$0 Hold
29
– – ﹤0.01% 3061
2019
Q1 		$0 Hold
29
– – ﹤0.01% 3050
2018
Q4 		$0 Buy
+29
New +$903 ﹤0.01% 3010
2017
Q3 		– Sell
-85
Closed -$1K – 2736
2017
Q2 		$1K Hold
85
– – ﹤0.01% 2576
2017
Q1 		$1K Buy
+85
New +$1.49K ﹤0.01% 2576
2016
Q4 		– Sell
-83
Closed -$1K – 2469
2016
Q3 		$1K Buy
+83
New +$1.28K ﹤0.01% 2452

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Glenmede Trust's ATRC Position: Q2 2020 in Review

Glenmede Trust sold out of AtriCure (ATRC) in Q2 2020, closing a stake of 29 shares.

Glenmede Trust first reported a position in ATRC in Q3 2016 and held it in 9 quarters. The position peaked at $1K in Q2 2017. 188 funds tracked by Wall St. Rank hold ATRC as of Q2 2020.

  • Glenmede Trust reported no remaining AtriCure position as of Q2 2020 after selling out during the quarter.
  • Glenmede Trust sold 29 AtriCure shares in Q2 2020.
  • Glenmede Trust first reported a position in AtriCure in Q3 2016 and held it in 9 quarters.
  • Glenmede Trust's AtriCure position peaked at $1K in Q2 2017.
  • 188 funds tracked by Wall St. Rank held AtriCure as of Q2 2020.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.